findmyKOL
Clinical trialNCT04778956RecruitingPhase 3Interventional

Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma

SponsorSun Yat-sen UniversityEnrollment218Nasopharyngeal CarcinomaPD-1Surgery
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Nanfang Hospital of Southern Medical University

    Guangzhou, Guangdong, China

    Not, yet, recruiting
  • Sun Yat-Sen University Cancer Center

    Guangzhou, Guangdong, China

    Recruiting
  • the Fifth Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, China

    Not, yet, recruiting
  • the First Affiliated Hospital, Sun Yat-Sen University

    Guangzhou, Guangdong, China

    Not, yet, recruiting
  • the First People'S Hospital of Foshan

    Guangzhou, Guangdong, China

    Not, yet, recruiting
  • Zhongshan People'S Hospital

    Zhongshan, Guangdong, China

    Not, yet, recruiting
  • the Tenth Affiliated Hospital, Sun Yat-Sen University

    Nanchang, Jiangxi, China

    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
3 Mar 2021
Primary completion
3 Mar 2025
Completion
3 Mar 2033
Last update posted
4 Mar 2021
Registered enrollment
218
Registry id
NCT04778956

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.